Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2005Medical MycologyOpen Access

Azole and fungicide resistance in clinical and environmentalAspergillus fumigatusisolates

View Full Paper
Ask AI
Bookmark
Share

Authors

IMIsabelle MeneauUniversity Hospital of ZurichDSDominique SanglardCzech Academy of Sciences, Institute of Microbiology

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Meneau et al. (2005) studied this question.

synapsesocial.com/papers/6aa504dbac77d5296f2bd617https://doi.org/10.1080/13693780500090826
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1National Committee for Clinical Laboratory Standards1980 · 14,792 citations
  2. 2<i>Aspergillus fumigatus</i> and Aspergillosis1999 · 2,315 citations
  3. 3Itraconazole resistance in Aspergillus fumigatus1997 · 513 citations
  4. 4Mutations in <i>Aspergillus fumigatus</i> Resulting in Reduced Susceptibility to Posaconazole Appear To Be Restricted to a Single Amino Acid in the Cytochrome P450 14α-Demethylase2003 · 189 citations
  5. 5Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene1997 · 585 citations